Navigation Links
Amgen Announces Voting Results Of Annual Meeting of Stockholders
Date:5/20/2011

SEATTLE, May 20, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN), today announced results of voting at the Company's Annual Meeting of Stockholders, held at The Fairmont Olympic Hotel in Seattle, Wash. Approximately 86.32 percent of outstanding shares were represented at the meeting.

The director nominees David Baltimore, Frank J. Biondi, Jr., Francois de Carbonnel, Vance D. Coffman, Rebecca M. Henderson, Frank C. Herringer, Gilbert S. Omenn, Judith C. Pelham, J. Paul Reason, USN (Retired), Leonard D. Schaeffer, Kevin W. Sharer and Ronald D. Sugar were each reelected to Amgen's Board of Directors, each receiving a majority of 'For' votes of the votes cast. With the reelection of these directors, Amgen currently has 12 directors.

With approximately 98.54 percent of 'For' votes of the votes cast, stockholders ratified Ernst & Young as Amgen's independent registered public accountants for the year ending Dec. 31, 2011.

Stockholders approved an advisory vote, commonly known as "Say-on-Pay." The non-binding proposal gives shareholders the opportunity to endorse or not endorse executive pay programs and policies. Say-on-Pay received approximately 55.58 percent of the votes cast 'For' the proposal. In connection with this advisory vote, stockholders voted that executive compensation should be voted on annually at 89.37 percent of the votes cast.

Stockholders approved a nonbinding resolution recommending that the Company take steps to permit shareholders to act by the written consent of the majority of shares outstanding. The proposal received approximately 50.19 percent of votes cast 'For' the proposal and approximately 38.10 percent of the votes outstanding 'For' the proposal.

About Amgen

Amgen discovers, develops, manufactures, and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first comp
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Amgen Receives CHMP Positive Opinion for XGEVA™ (Denosumab) in the European Union
2. Amgen Oncology Data to be Presented at ASCO Annual Meeting
3. Amgen to Webcast Investor Meeting at Upcoming American Urological Association Conference
4. Five Californians Selected as Breakaway from Cancer® Champions to be Honored During Amgen Tour of California
5. Amgen to Present at the Deutsche Bank 36th Annual Healthcare Conference
6. Amgen Outlines Strategy, Growth Objectives and Capital Allocation Plans
7. Amgen and UCB Announce Positive Phase 2 Results of AMG 785/CDP7851 in Patients With Postmenopausal Osteoporosis (PMO)
8. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
9. Amgen to Webcast 2011 Business Review Meeting on April 21
10. Amgen Announces Webcast of 2011 First Quarter Financial Results
11. Amgen Establishes Commercial Operations in Brazil
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... July 11, 2014 According to ... "Endoscopy Devices Market (Endoscopes, Endoscopic Operative Devices, and Visualization ... and Forecast, 2013-2019" the global endoscopy devices market was ... expected to grow at a CAGR of 6.8% from ... USD 36.9 billion in 2019. Browse the ...
(Date:7/11/2014)... 2014 Neurelis, Inc. ("Neurelis") today announced an ... option held by Biotie to purchase Neurelis, clearing the ... (intranasal diazepam) for pediatric and adult epilepsy patients who ... year, Biotie has advanced the development program for NRL-1 ... clinical work required for NDA submission to the FDA.  ...
(Date:7/10/2014)... 2014  Breg, Inc., a premier provider of ... FreeRunner™ knee brace with new innovations to help ... return to active lifestyles.  FreeRunner,s patent-pending design acts ... support when patients need it most, and the ... Patellofemoral issues are the most common cause ...
Breaking Medicine Technology:Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 2Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 3Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 4Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 5Global Endoscopy Devices Market is Expected to Reach USD 36.9 Billion by 2019: Transparency Market Research 6Neurelis Regains Rights to Intranasal Diazepam Program 2Neurelis Regains Rights to Intranasal Diazepam Program 3Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2
... study results also demonstrate the longest duration of consistently ... levels shown by a cervical cancer vaccine, TAMPA, ... GSK ) cervical cancer candidate vaccine,CERVARIX(R) provides significant ... human papillomavirus types for nearly six and a half,years, ...
... SOUTH SAN FRANCISCO, Calif., March 10 ... clinical-stage biopharmaceutical,company focused on the discovery, development ... positive interim data,from the company,s ongoing Phase ... SNS-595, in platinum-resistant ovarian cancer patients., ...
Cached Medicine Technology:GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 2GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 3GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 4GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 5GSK Cervical Cancer Candidate Vaccine CERVARIX (R) Demonstrates Long-Term Protection for More Than Six Years 6Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer 2Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer 3Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer 4Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer 5
(Date:7/11/2014)... Steven Reinberg HealthDay ... A potential vaccine to protect children from the worldwide scourge ... Asian children. While the vaccine only prevented dengue fever ... full series of three shots, it protected more than 88 ... dengue fever can lead to hospitalization, and sometimes death. ...
(Date:7/11/2014)... Ticket Down is a reliable source for cheap ... in Wheatland, CA. In the Sacramento California area there ... Train Amphitheatre can do for music fans. The venue has ... of its existence and can seat 18,500 fans each night. ... metro area) will host the “That’s My Kind of Night” ...
(Date:7/11/2014)... 11, 2014 Europe is one of ... large cultivated-and hence, irrigated land area. The agricultural sector ... accounting for around 30.0% of the total water use. ... in the southern region, but far from negligible in ... accounts for over 60.0% of the water use in ...
(Date:7/11/2014)... have been trying to unravel mechanisms that guide function ... generate all blood cells including our immune system. The ... they can only be found in the bone marrow ... culture dish. Now a group of scientists from Dresden ... Universitt Dresden) was able to generate a mouse model ...
(Date:7/11/2014)... Experience Mayan heritage and enjoy the spirit ... the luxury all-inclusive AAA Five Diamond Grand Velas Riviera ... ecological family tour where guests learn about local flora ... Tour at the Mayan archeological site of Coba. Guests ... the Yucatan and the only pyramid people are still ...
Breaking Medicine News(10 mins):Health News:Dengue Fever Vaccine Shows Some Promise in Trial 2Health News:Dengue Fever Vaccine Shows Some Promise in Trial 3Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 2Health News:Luke Bryan Tickets Sleep Train Amphitheatre in Wheatland, CA (Sacramento): Ticket Down has Slashed Ticket Prices on Luke Bryan in Wheatland at Sleep Train 3Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 2Health News:Europe Micro Irrigation System Market Driven by Growing Environmental Concerns and Decreasing Water Availability - New Report by MicroMarket Monitor 3Health News:Opening-up the stem cell niche 2Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 2Health News:Explore the Aura and Mystery of the Yucatan’s Mayan Culture with New Hotel Package at AAA Five Diamond Grand Velas Riviera Maya 3
... (Aug. 25, 2009) The Henry M. Jackson Foundation ... three promising Uniformed Services University of the Health Sciences ... year. The program, established in 1988, is comprised of ... Hemming Fellowship. Each fellow receives a stipend and travel ...
... The University of Nottingham and Health Protection Agency East Midlands ... after being commissioned as part of the government,s response to ... long someone is contagious for and advise on a ,safe ... by Professor Jonathan Nguyen Van Tam of the University of ...
... YORK, August 25, 2009 -- Charleen T. Chu, MD, ... David M. Sabatini, MD, PhD, associate professor, Massachusetts Institute ... in Aging Research. Sponsored by The Ellison Medical ... scientists whose research has great potential in advancing understanding ...
... , , SAN ... of Bone and Joint Surgery demonstrates that use of ... effective than both DuraPrep and povidone-iodine at eliminating overall bacteria ... chlorhexidine gluconate and 70 percent isopropyl alcohol), only seven percent ...
... , , , , ... Judd is speaking up for those struggling with chronic pain -- a ... combined. Judd is lending her voice to the national education program ... instpain.com ) to raise awareness about the urgent need to ...
... SAN RAFAEL, Calif., Aug. 25 TBI/Tissue Banks International, one of ... Services (NWTS), a Puget Sound Blood Center program, have entered into ... surgeons and hospitals that rely on them for transplantable tissue. ... immediately, allows TBI to distribute tissue recovered and processed by NWTS ...
Cached Medicine News:Health News:Henry M. Jackson Foundation names fellowship award winners 2Health News:Nottingham scientists commissioned for urgent swine flu research 2Health News:Ellison Medical Foundation awards more than $1 million to mid-career scientists 2Health News:New Data Show ChloraPrep(R) Significantly More Effective Than DuraPrep(TM) and Povidone-Iodine in Eliminating Bacteria From Skin Prior to Shoulder Surgery 2Health News:New Data Show ChloraPrep(R) Significantly More Effective Than DuraPrep(TM) and Povidone-Iodine in Eliminating Bacteria From Skin Prior to Shoulder Surgery 3Health News:New Data Show ChloraPrep(R) Significantly More Effective Than DuraPrep(TM) and Povidone-Iodine in Eliminating Bacteria From Skin Prior to Shoulder Surgery 4Health News:New Data Show ChloraPrep(R) Significantly More Effective Than DuraPrep(TM) and Povidone-Iodine in Eliminating Bacteria From Skin Prior to Shoulder Surgery 5Health News:Country Legend Naomi Judd Joins 'Partners Against Pain' 2Health News:Country Legend Naomi Judd Joins 'Partners Against Pain' 3Health News:TBI/Tissue Banks International and Northwest Tissue Services Announce Collaborative Distribution Agreement 2
... is an effective angina relief ... poor targets. Because it is ... the CO2 Heart Laser 2 ... timely operative decisions to revascularize ...
Ultrasensitive TSH EIA Thyroid Function 025-BC-1003...
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin...
... The anti-TG test kit is a solid ... format. It is designed for the quantitative ... (TG) in serum or plasma. The microplate ... Calibrators, controls and patient samples are pipetted ...
Medicine Products: